Scilex Holding Company Payments of Merger Related Costs, Financing Activities
Scilex Holding Company (SCLX) reported Payments of Merger Related Costs, Financing Activities of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2026-08-14
- Scilex Holding Company payments of merger related costs, financing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Scilex Holding Company payments of merger related costs, financing activities for the quarter ending 2025-09-30 was -$263.00K.
- Scilex Holding Company payments of merger related costs, financing activities for the quarter ending 2025-06-30 was $168.00K.
- Scilex Holding Company payments of merger related costs, financing activities for the quarter ending 2025-03-31 was $95.00K.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 9 month |
|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-20 | ||
| 2025-09-30 | -$263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$95.00K derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $263.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $95.00K 10-Q · filed 2026-05-20 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |